Literature DB >> 3491693

Complement abnormalities during an epidemic of group B meningococcal infection in children.

D W Beatty, C R Ryder, H D Heese.   

Abstract

During an epidemic of group B meningococcal infection mean values obtained in 96 consecutively affected children showed a reduction in classical pathway function (CH50), normal alternate pathway function (AP50), C4 and factor B levels, and raised C3 levels. CH50, C3 and Factor B were however significantly lower in those children who had a rapid onset of illness, were in shock, had signs of septicaemia, had extensive skin purpura, or who died. The presence of detectable meningococcal antigen by Counter Immuno Electrophoresis (CIE) and laboratory evidence of Disseminated Intravascular Coagulation (DIC) also correlated with lower complement levels. The significant reduction in CH50 and Factor B in the more severely affected patients suggests that activation of both classical and alternate pathways occurs in group B meningococcal infection.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3491693      PMCID: PMC1542439     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  12 in total

1.  Plasma levels of complement components and complement haemolytic activity in protein-energy malnutrition.

Authors:  L Haller; R H Zubler; P H Lambert
Journal:  Clin Exp Immunol       Date:  1978-11       Impact factor: 4.330

2.  Group-specific polysaccharide antigen and humoral antibody response in disease due to Neisseria meningitidis.

Authors:  T A Hoffman; E A Edwards
Journal:  J Infect Dis       Date:  1972-12       Impact factor: 5.226

3.  The potential pathogenic role of complement in dengue hemorrhagic shock syndrome.

Authors:  V A Bokisch; F H Top; P K Russell; F J Dixon; H J Müller-Eberhard
Journal:  N Engl J Med       Date:  1973-11-08       Impact factor: 91.245

4.  Immunologic investigations of meningococcal disease. I. Group-specific Neisseria meningitidis antigens present in the serum of patients with fulminant meningococcemia.

Authors:  E A Edwards
Journal:  J Immunol       Date:  1971-02       Impact factor: 5.422

5.  Development of human complement system.

Authors:  P Fireman; D A Zuchowski; P M Taylor
Journal:  J Immunol       Date:  1969-07       Impact factor: 5.422

6.  [Determination of total hemolytic complement and C3 component in patients with meningococcal meningitis].

Authors:  M A Ribeiro; C Fava Netto; M C dos Santos
Journal:  Rev Inst Med Trop Sao Paulo       Date:  1981 Sep-Oct       Impact factor: 1.846

7.  Complement and meningococcal infection.

Authors:  B M Greenwood; I I Onyewotu; H C Whittle
Journal:  Br Med J       Date:  1976-04-03

8.  Meningococcal septicaemia treated with combined plasmapheresis and leucapheresis or with blood exchange.

Authors:  B Bjorvatn; L Bjertnaes; H O Fadnes; T Flaegstad; T J Gutteberg; B E Kristiansen; J Pape; O P Rekvig; B Osterud; L Aanderud
Journal:  Br Med J (Clin Res Ed)       Date:  1984-02-11

9.  Endotoxin in meningococcal infections.

Authors:  H R Tubbs
Journal:  Arch Dis Child       Date:  1980-10       Impact factor: 3.791

10.  Human immunity to the meningococcus. I. The role of humoral antibodies.

Authors:  I Goldschneider; E C Gotschlich; M S Artenstein
Journal:  J Exp Med       Date:  1969-06-01       Impact factor: 14.307

View more
  8 in total

1.  Features and outcome in meningococcal disease presenting with maculopapular rash.

Authors:  O Marzouk; A P Thomson; J A Sills; C A Hart; F Harris
Journal:  Arch Dis Child       Date:  1991-04       Impact factor: 3.791

Review 2.  Interaction of complement with Neisseria meningitidis and Neisseria gonorrhoeae.

Authors:  P Densen
Journal:  Clin Microbiol Rev       Date:  1989-04       Impact factor: 26.132

Review 3.  Infections of people with complement deficiencies and patients who have undergone splenectomy.

Authors:  Sanjay Ram; Lisa A Lewis; Peter A Rice
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

Review 4.  Infectious diseases associated with complement deficiencies.

Authors:  J E Figueroa; P Densen
Journal:  Clin Microbiol Rev       Date:  1991-07       Impact factor: 26.132

5.  Deficiency of the sixth component of complement and susceptibility to Neisseria meningitidis infections: studies in 10 families and five isolated cases.

Authors:  A Orren; P C Potter; R C Cooper; E du Toit
Journal:  Immunology       Date:  1987-10       Impact factor: 7.397

6.  Inherited complement deficiency in children surviving fulminant meningococcal septic shock.

Authors:  H H Derkx; E J Kuijper; C A Fijen; M Jak; J Dankert; S J van Deventer
Journal:  Eur J Pediatr       Date:  1995-09       Impact factor: 3.183

7.  Complement activation in relation to capillary leakage in children with septic shock and purpura.

Authors:  J A Hazelzet; R de Groot; G van Mierlo; K F Joosten; E van der Voort; A Eerenberg; M H Suur; W C Hop; C E Hack
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

Review 8.  Meningococcal disease and the complement system.

Authors:  Lisa A Lewis; Sanjay Ram
Journal:  Virulence       Date:  2013-10-08       Impact factor: 5.882

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.